Carcinoembryonic antigen in tissue and serum from breast cancer patients relationship with steroid receptors and clinical applications in the prognosis and early diagnosis of relapse

Anticancer Research

Volumn 19, Issue 4 A, 1999, Pages 2557-2562

  Molina, Rafael ^a   Farrus, B ^a   Filella, X ^a   Jo, J ^a   Zanon G ^a   Pahisa, J ^a   Latre, M ^a   Munoz M ^a   Ballesta, A M ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Breast cancer; Carcinoembryonic antigen; CEA; Early detection of relapse; Estrogen receptor; Tumor associated antigens; Tumor markers

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; STEROID RECEPTOR;

BREAST CANCER; BREAST METASTASIS; CONFERENCE PAPER; CYTOSOL; EARLY DIAGNOSIS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; RECURRENT CANCER; RELAPSE; SERUM;

BREAST; BREAST DISEASES; BREAST NEOPLASMS; CARCINOEMBRYONIC ANTIGEN; CYTOSOL; FEMALE; HUMANS; IMMUNORADIOMETRIC ASSAY; LYMPHATIC METASTASIS; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RETROSPECTIVE STUDIES;

EID: 0032800774     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (29)

1. Hayes DF, Zurawski VR, Kufe DW: Comparison of circulating CA 15.3 and carcinoembryonic antigen levels in patients with breast cancer. J Clin Oncol 4: 1542-1546, 1986.
2. Molina R, Filella X, Mengual P, et al: MCA in patients with breast cancer: correlation with CEA and CA 15.3. Int J Biol Markers 5: 14-21, 1990.
3. Kuhajda FP, Offutt LE, Mendelsohn G: The distribution of carcino-embryonic antigen in breast carcinoma. Diagnostic and prognostic implications. Cancer 52: 1257-1264, 1983.
4. Haagensen DE, Kister SJ, Vandeveerde JP, et al: Evaluation of carcinoembryonic antigen as a plasma monitor for human breast carcinoma. Cancer 42: 1512-1519, 1978.
5. Franchimont P, Zangerle PF, Hendrick JC, Reuter S, Colin C: Simultaneous assays of cancer associated antigens in benign and malignant breast diseases. Cancer 39: 2806-2812, 1977.
6. Tormey DC, Waalkes TP, Ahmann D, et al: Biological markers in breast carcinoma I. Incidence of abnormalities of CEA, HGC, three polyamines and three minor nucleosides. Cancer 35: 1095-1100, 1975.
7. Wang DY, Bulbrock RD, Hayward JL, Hendrick JC, Franchimont P: Relationship between plasma carcinoembryonic antigen and prognosis in women with breast cancer. Europ J Cancer 11: 615-618, 1975.
8. Staab HJ, Anderer FA, Alehmann FL, Frommhold W: CEA monitoring and management of patients with carcinoma of the breast, lung, bladder, kidney and esophagus in radiotherapy. In: Carcino-embryonic proteins, vol I (Lehmann H ed).Amsterdam, Elsevier North Holland, 1979,pp 151-161.
9. Neville AM, Patel S, Capp M, et al: The monitoring role of plasma CEA alone and in association with other tumor markers in colorectal and mammary carcinoma. Cancer 42: 1448-1451, 1978.
10. Chatal JF, Chupin F, Ricolleau G, et al: Use of serial carcino-embryonic antigen assays in detecting relapses in breast cancer involving high risk of metastases. Europ J Cancer 17: 233- 238, 1981.
11. Molina R, Zanon G, Filella X et al: Use of serial carcinoembryonic antigen and CA 15.3 assays in detecting relapses in breast cancer patients. Br Cancer Res Treat 36: 41-48, 1995.
12. Coombes R, Powless T, Gazet J, et al: Screening for metastases in breast cancer: an assessment of biochemical and physical methods. Cancer 48: 310-315, 1981.
13. Staab HJ, Anderes FA, Koch HL, Ahlemann LM: Serial CEA determinations in the management of patients with breast cancer. Oncodevelop Biol Med I: 151-160, 1980.
14. Tormey DC, Waalkes TP, Snyder JJ, Simon RM: Biological markers in breast carcinoma. Clinical correlations with carcinoembryonic antigen. Cancer 39: 2397-2403, 1977.
15. Ahlemann LM, Staab HJ, Hubener KH, Anderer FA: CEA as an additional prognostic factor to the TNM. J Cancer Res Clin Oncol 107: 101-108, 1984.
16. Bhataudekar JM, Karelia NH, Shukla MK, Ghosh N: Prognosis in breast carcinoma utilizing plasma carcinoembryonic antigen and histologic characteristics of the primary tumor. Tumor Biol 8: 233-240, 1987.
17. Mansour EG, Hastert M, Park CH, Koehler KA, Petrelli M: Tissue and plasma carcinoembryonic antigen in early breast cancer. A prognostic factor. Cancer 51: 1243-1248, 1983.
18. Shousha J, Lyssiotis T, Godfrey V, et al: Carcinoembryonic antigen in breast cancer tissue, a useful prognostic indicator Br Med J 1: 777-779, 1979.
19. Shively JE, Todd CW: Carcinoembryonic antigen. In: Ruoslahti E, Engwall E eds. Chemistry of Tumor-associated antigens. Sc J Immunol 6 (7): 19-32, 1978.
20. Bradford MA: A rapid and sensitive method for the quantification of micrograms quantities of protein utilizing the principle of protein dyebinding. Anal Biochem 72: 248-254, 1976.
21. Horowitz JD, Au FC, Tang CK, Stein B, Campana TJ: Tissue carcinoembryonic antigen levels in benign and malignant diseases of the breast. J Surg Oncology 40: 58-60, 1989.
22. von Kleist S, Wachner R, Grunert F, Wittekind C: Immuno-histological determination of CEA in breast tumors: comparison of monoclonal and polyclonal antibodies. In: Protides of the Biological Fluids vol 32 (Peeters H de), Oxford, Pergamon Press, 1984, pp325-328.
23. Nap M, Fleuren GJ: Immnunohistological localization of carcino-embryonic antigen and nonspecific cross reacting antibodies in benign breast lesions. In: Protides of the Biological Fluids vol 31 (Peeters H ed). Oxford, Pergamon Press, 1984, pp329-332.
24. Duffy MJ, O'Conell M, O'Sullivan F, McKenna B, Allen MA, McDonell L: CEA-like material in cytosols from human breast carcinomas. Correlation with biochemical and pathological parameters. Cancer 51: 121-123, 1983.
25. Gion M, Mione R, Dittadi R, et al: Carcinoembryonic antigen, ferritin and tissue polypepiide antigen in serum and tissue. Relationship with receptor content in breast carcinoma. Cancer 57: 917-922, 1986.
26. Schwartz MR, Randolph RL, Panko WB: Carcinoembryonic antigen and steroid receptors in the cytosol of carcinoma of the breast. Relationship to pathologic and clinical features. Cancer 55: 2464-2471, 1985.
27. Molina R, Ballesta AM, Rivera Fillat F, Casals E, Balague A: Value of determination of CEA and PHI levels in breast tissue: correlation with steroid receptors. In: Protides of the Biological Fluids vol 32(Peeters H ed). Oxford, Pergamon Press, 1985, pp 843-846.
28. Molina R, Ballestȧ AM, Rivera-Fillat F, Balague A: Study of the carcinoembryonic antigen (CEA) and estrogen receptors (ER) in breast cancer tissue. In: I Marker tumorali in Ginecologia (Coli AC, Torre GC, Vechione A, Zacutti Jr A. eds). Roma, CIC Edizione Internazionali, 1985, pp491-504.
29. Molina R, Jo J, Zanon G, et al: Utility of C-erbB-2 in tissue and in serum in the early diagnosis of recurrence in breast cancer patients: comparison with carcinoembryonic antigen and CA 15.3. Br J Cancer 74: 1126-1131, 1996.